• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格雷夫斯眼病:10Gy与24Gy照射联合全身皮质类固醇治疗的磁共振成像评估

Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.

作者信息

Nakahara H, Noguchi S, Murakami N, Morita M, Tamaru M, Ohnishi T, Hoshi H, Jinnouchi S, Nagamachi S, Futami S

机构信息

Noguchi Thyroid Clinic, Oita, Japan.

出版信息

Radiology. 1995 Sep;196(3):857-62. doi: 10.1148/radiology.196.3.7644656.

DOI:10.1148/radiology.196.3.7644656
PMID:7644656
Abstract

PURPOSE

To establish the most effective radiation dose for treatment of Graves ophthalmopathy (GO).

MATERIALS AND METHODS

A combination of 10 Gy (n = 15) or 24 Gy (n = 16) of radiation and corticosteroids was used to treat 31 patients with GO. Magnetic resonance (MR) images obtained before treatment showed swollen extraocular muscles with prolonged T2 relaxation times in all patients.

RESULTS

Before therapy, T2 relaxation time of extraocular muscle was 79.6 msec (95% confidence interval, 76.3, 82.9) in the 24-Gy group and 77.4 msec (95% confidence interval, 74.6, 80.1) in the 10-Gy group (P = .32). After therapy, T2 relaxation time was 62.8 msec (95% confidence interval, 61.2, 64.4) in the 24-Gy group and 68.9 msec (95% confidence interval, 66.8, 71.1) in the 10-Gy group. In the 24-Gy group, there was a significant decrease in T2 relaxation times (P = .001) and clinical response to initial treatment was better. At 1- and 3-month follow-up, the resistance rate was lower in the 24-Gy group.

CONCLUSION

In treatment of GO, 24 Gy of radiation is a more effective dose than 10 Gy when combined with systemic corticosteroids.

摘要

目的

确定治疗格雷夫斯眼病(GO)的最有效辐射剂量。

材料与方法

采用10 Gy(n = 15)或24 Gy(n = 16)辐射与皮质类固醇联合治疗31例GO患者。治疗前获得的磁共振(MR)图像显示所有患者的眼外肌肿胀,T2弛豫时间延长。

结果

治疗前,24 Gy组眼外肌的T2弛豫时间为79.6毫秒(95%置信区间,76.3, 82.9),10 Gy组为77.4毫秒(95%置信区间,74.6, 80.1)(P = 0.32)。治疗后,24 Gy组的T2弛豫时间为62.8毫秒(95%置信区间,61.2, 64.4),10 Gy组为68.9毫秒(95%置信区间,66.8, 71.1)。在24 Gy组,T2弛豫时间显著缩短(P = 0.001),对初始治疗的临床反应更好。在1个月和3个月的随访中,24 Gy组的抵抗率较低。

结论

在GO的治疗中,与全身皮质类固醇联合使用时,24 Gy的辐射剂量比10 Gy更有效。

相似文献

1
Graves ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids.格雷夫斯眼病:10Gy与24Gy照射联合全身皮质类固醇治疗的磁共振成像评估
Radiology. 1995 Sep;196(3):857-62. doi: 10.1148/radiology.196.3.7644656.
2
Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.格雷夫斯眼病中的眼外肌:T2弛豫时间测量的作用
Radiology. 1994 Mar;190(3):857-62. doi: 10.1148/radiology.190.3.8115640.
3
[MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].[在内分泌性眼眶病中使用和不使用选择性脂肪抑制(SPIR)进行磁共振弛豫时间测量]
Rofo. 1997 Dec;167(6):557-64. doi: 10.1055/s-2007-1015583.
4
Graves ophthalmopathy: role of MR imaging in radiation therapy.格雷夫斯眼病:磁共振成像在放射治疗中的作用
Radiology. 1991 Apr;179(1):187-90. doi: 10.1148/radiology.179.1.2006276.
5
Protracted hypofractionated radiotherapy for Graves' ophthalmopathy: a pilot study of clinical and radiologic response.Graves 眼病的迁延性低分割放射治疗:临床和影像学反应的初步研究。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1285-91. doi: 10.1016/j.ijrobp.2010.09.015. Epub 2011 May 6.
6
Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy.静脉注射甲泼尼龙冲击疗法治疗格雷夫斯眼病。
Endocr J. 1993 Feb;40(1):63-72. doi: 10.1507/endocrj.40.63.
7
Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.三维眼眶磁共振T2成像在格雷夫斯眼病患者评估中的应用
J Huazhong Univ Sci Technolog Med Sci. 2017 Dec;37(6):938-942. doi: 10.1007/s11596-017-1831-8. Epub 2017 Dec 21.
8
Orbital cobalt irradiation combined with systemic corticosteroids for Graves' ophthalmopathy: comparison with systemic corticosteroids alone.眼眶钴照射联合全身用皮质类固醇治疗格雷夫斯眼病:与单纯全身用皮质类固醇的比较
J Clin Endocrinol Metab. 1983 Jun;56(6):1139-44. doi: 10.1210/jcem-56-6-1139.
9
Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.眼眶钴放射治疗及全身或球后注射皮质类固醇治疗格雷夫斯眼病
Horm Res. 1987;26(1-4):177-83. doi: 10.1159/000180698.
10
[Treatment of Grave's ophthalmopathy with high doses of corticosteroids].[大剂量皮质类固醇治疗格雷夫斯眼病]
Srp Arh Celok Lek. 2000 May-Jun;128(5-6):179-83.

引用本文的文献

1
Orbital Radiotherapy for Graves' Ophthalmopathy: Single Institutional Experience of Efficacy and Safety.眼眶放射治疗Graves眼病:单机构疗效与安全性经验
Diseases. 2025 Feb 17;13(2):61. doi: 10.3390/diseases13020061.
2
Teprotumumab as a Novel Therapy for Thyroid-Associated Ophthalmopathy.特罗特鲁单抗治疗甲状腺相关眼病的新疗法。
Front Endocrinol (Lausanne). 2020 Dec 17;11:610337. doi: 10.3389/fendo.2020.610337. eCollection 2020.
3
Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.胰岛素样生长因子-I受体与甲状腺相关性眼病
Endocr Rev. 2019 Feb 1;40(1):236-267. doi: 10.1210/er.2018-00066.
4
Update on thyroid eye disease and management.甲状腺眼病及其治疗的最新进展
Clin Ophthalmol. 2009;3:543-51. doi: 10.2147/opth.s5228. Epub 2009 Oct 19.
5
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy.回顾性研究全身激素治疗联合 12、16 和 20Gy 总吸收眶剂量治疗格雷夫斯眼病患者的疗效。
Graefes Arch Clin Exp Ophthalmol. 2010 Jan;248(1):103-9. doi: 10.1007/s00417-009-1214-3. Epub 2009 Oct 29.
6
[Endocrine orbitopathy 1998].[内分泌性眼眶病1998年]
Med Klin (Munich). 1998 Jun 15;93(6):365-73. doi: 10.1007/BF03044681.